A Study in Advanced Solid Tumors

NCT01063075 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Cetuximab
DRUG: Carboplatin
DRUG: 5 - FU

Sponsor

Eli Lilly and Company